Tempus AI (TEM) EV/EBIT: History & Chart

Tempus AI, Inc.(TEM)

Medical - Healthcare Information Services · Chicago, IL

$58.74-2.54 (-4.14%)

Delayed quote: Sep 10, 2026, 4:00 PM EDT

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$10.29B	N/A	N/A	N/A	N/A
Molina Healthcare, Inc. (MOH)vs ›	$10.45B	31.83x	12.76x	11.23x	12.43x
Universal Health Services, Inc. (UHS)vs ›	$10.46B	7.57x	8.78x	11.25x	11.63x
The Ensign Group, Inc. (ENSG)vs ›	$10.07B	25.80x	30.43x	30.19x	26.91x
The Cooper Companies, Inc. (COO)vs ›	$10.56B	23.80x	26.13x	30.94x	34.80x
Henry Schein, Inc. (HSIC)vs ›	$9.94B	17.57x	16.38x	16.63x	15.59x
Bio-Rad Laboratories, Inc. (BIO)vs ›	$9.93B	45.16x	39.56x	33.48x	33.07x
Globus Medical, Inc. (GMED)vs ›	$9.92B	14.59x	25.38x	55.45x	46.47x
Align Technology, Inc. (ALGN)vs ›	$10.79B	17.78x	19.29x	24.30x	28.51x
Insulet Corp. (PODD)vs ›	$9.33B	18.89x	37.14x	62.69x	172.02x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Tempus AI, Inc. (TEM)

$10.29B

N/A

Molina Healthcare, Inc. (MOH)vs ›

$10.45B

31.83x

12.76x

11.23x

12.43x

Universal Health Services, Inc. (UHS)vs ›

$10.46B

7.57x

8.78x

11.25x

11.63x

The Ensign Group, Inc. (ENSG)vs ›

$10.07B

25.80x

30.43x

30.19x

26.91x

The Cooper Companies, Inc. (COO)vs ›

$10.56B

23.80x

26.13x

30.94x

34.80x

Henry Schein, Inc. (HSIC)vs ›

$9.94B

17.57x

16.38x

16.63x

15.59x

Bio-Rad Laboratories, Inc. (BIO)vs ›

$9.93B

45.16x

39.56x

33.48x

33.07x

Globus Medical, Inc. (GMED)vs ›

$9.92B

14.59x

25.38x

55.45x

46.47x

Align Technology, Inc. (ALGN)vs ›

$10.79B

17.78x

19.29x

24.30x

28.51x

Insulet Corp. (PODD)vs ›

$9.33B

18.89x

37.14x

62.69x

172.02x

EV/EBIT Ratio: N/A

TEM EV/EBIT Ratio Metrics

TEM Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics